FDA Inspection 1342112 — ADMA BioCenters Georgia Inc.
The FDA completed an inspection of ADMA BioCenters Georgia Inc. on Aug 20, 2026 in Dallas, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 20, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, GA (United States)